BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 34267018)

  • 21. [From the Standpoint of a Core Center Hospital for Cancer Genome Medicine-Establishment of a Provision System for Wide-Area Precision Oncology].
    Muto M; Kondo T; Yoshioka M; Fukuyama K; Suga J; Sato M; Masuda F; Ashida K; Mukai K; Matsumoto S; Kanai M
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):866-872. PubMed ID: 34267018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment and implementation of Cancer Genomic Medicine in Japan.
    Mukai Y; Ueno H
    Cancer Sci; 2021 Mar; 112(3):970-977. PubMed ID: 33289217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current Clinical Practice of Precision Medicine Using Comprehensive Genomic Profiling Tests in Biliary Tract Cancer in Japan.
    Kanai M
    Curr Oncol; 2022 Sep; 29(10):7272-7284. PubMed ID: 36290850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer genomic medicine in Japan.
    Mano H
    Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(7):316-321. PubMed ID: 32788553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospects and Problems of Cancer Genome Analysis for Establishing Cancer Precision Medicine.
    Hayashi T; Konishi I
    Cancer Invest; 2019; 37(9):427-431. PubMed ID: 31451055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer genomic medicine in Japan and the roles of pharmacists.
    Aomori T; Sakurai H; Nishihara H
    Pharmacogenet Genomics; 2022 Aug; 32(6):242-245. PubMed ID: 35696282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Precision Oncology and the Universal Health Coverage System in Japan.
    Ebi H; Bando H
    JCO Precis Oncol; 2019; 3():. PubMed ID: 32923862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Background and prospects of the Community Health Act].
    Aoyama H
    Nihon Eiseigaku Zasshi; 1996 Feb; 50(6):1026-35. PubMed ID: 8720929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next-generation sequencing: from conventional applications to breakthrough genomic analyses and precision oncology.
    Ziogas DE; Kyrochristos ID; Roukos DH
    Expert Rev Med Devices; 2018 Jan; 15(1):1-3. PubMed ID: 29284319
    [No Abstract]   [Full Text] [Related]  

  • 30. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
    Syn NL; Yong WP; Goh BC; Lee SC
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementing precision cancer medicine in the genomic era.
    Chen HZ; Bonneville R; Roychowdhury S
    Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics.
    Mousses S; Kiefer J; Von Hoff D; Trent J
    Oncogene; 2008 Dec; 27 Suppl 2():S58-66. PubMed ID: 19956181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomics and bioinformatics as pillars of precision medicine in oncology.
    Canzoneri R; Lacunza E; Abba MC
    Medicina (B Aires); 2019; 79(Spec 6/1):587-592. PubMed ID: 31864231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The current status and problems confronted in delivering precision medicine in Japan and Europe.
    Bando H
    Curr Probl Cancer; 2017; 41(3):166-175. PubMed ID: 28391973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
    Cheng F; Hong H; Yang S; Wei Y
    Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Precision medicine in hematological malignancies].
    Yasuda T; Horibe K
    Rinsho Ketsueki; 2019; 60(9):1386-1395. PubMed ID: 31597868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translating genomics for precision cancer medicine.
    Roychowdhury S; Chinnaiyan AM
    Annu Rev Genomics Hum Genet; 2014; 15():395-415. PubMed ID: 25184532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Roles of Pharmacists in Cancer Genomic Medicine].
    Terada T
    Yakugaku Zasshi; 2020; 140(5):663-666. PubMed ID: 32378668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Drug research in oncology; advances in the genome era].
    Bins S; Schellens JH; Voest EE; Sleijfer S
    Ned Tijdschr Geneeskd; 2014; 158():A6801. PubMed ID: 24618235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Implementing next-generation sequencing for precision hematology/oncology].
    Maeda T
    Rinsho Ketsueki; 2018; 59(10):1924-1934. PubMed ID: 30305493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.